UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:ASRGL1-MYBL2 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: ASRGL1-MYBL2 | FusionPDB ID: 7246 | FusionGDB2.0 ID: 7246 | Hgene | Tgene | Gene symbol | ASRGL1 | MYBL2 | Gene ID | 80150 | 4605 |
Gene name | asparaginase and isoaspartyl peptidase 1 | MYB proto-oncogene like 2 | |
Synonyms | ALP|ALP1|CRASH | B-MYB|BMYB | |
Cytomap | 11q12.3 | 20q13.12 | |
Type of gene | protein-coding | protein-coding | |
Description | isoaspartyl peptidase/L-asparaginaseL-asparaginaseL-asparagine amidohydrolaseasparaginase like 1asparaginase-like 1 proteinasparaginase-like protein 1beta-aspartyl-peptidaseisoaspartyl dipeptidasetestis secretory sperm-binding protein Li 242mP | myb-related protein Bmyb-like protein 2v-myb avian myeloblastosis viral oncogene homolog-like 2v-myb myeloblastosis viral oncogene homolog-like 2 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q7L266 | P10244 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000301776, ENST00000415229, ENST00000528206, ENST00000535727, | ENST00000217026, ENST00000396863, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 16 X 12 X 4=768 | 9 X 9 X 4=324 |
# samples | 19 | 10 | |
** MAII score | log2(19/768*10)=-2.01510689239021 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/324*10)=-1.6959938131099 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: ASRGL1 [Title/Abstract] AND MYBL2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ASRGL1(62123847)-MYBL2(42341699), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | ASRGL1-MYBL2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ASRGL1-MYBL2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ASRGL1-MYBL2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ASRGL1-MYBL2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ASRGL1 | GO:0033345 | asparagine catabolic process via L-aspartate | 19839645 |
Tgene | MYBL2 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 10770937 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS5.0 | N/A | AI655904 | ASRGL1 | chr11 | 62123847 | - | MYBL2 | chr20 | 42341699 | - |
ChiTaRS5.0 | N/A | BF056302 | ASRGL1 | chr11 | 62123847 | - | MYBL2 | chr20 | 42341699 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000415229 | ASRGL1 | chr11 | 62123847 | - | ENST00000396863 | MYBL2 | chr20 | 42341699 | - | 1054 | 497 | 16 | 471 | 151 |
ENST00000415229 | ASRGL1 | chr11 | 62123847 | - | ENST00000217026 | MYBL2 | chr20 | 42341699 | - | 1232 | 497 | 16 | 471 | 151 |
ENST00000301776 | ASRGL1 | chr11 | 62123847 | - | ENST00000396863 | MYBL2 | chr20 | 42341699 | - | 972 | 415 | 820 | 404 | 138 |
ENST00000301776 | ASRGL1 | chr11 | 62123847 | - | ENST00000217026 | MYBL2 | chr20 | 42341699 | - | 1150 | 415 | 480 | 1 | 160 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000415229 | ENST00000396863 | ASRGL1 | chr11 | 62123847 | - | MYBL2 | chr20 | 42341699 | - | 0.15207547 | 0.84792453 |
ENST00000415229 | ENST00000217026 | ASRGL1 | chr11 | 62123847 | - | MYBL2 | chr20 | 42341699 | - | 0.42475227 | 0.57524776 |
ENST00000301776 | ENST00000396863 | ASRGL1 | chr11 | 62123847 | - | MYBL2 | chr20 | 42341699 | - | 0.11012047 | 0.8898795 |
ENST00000301776 | ENST00000217026 | ASRGL1 | chr11 | 62123847 | - | MYBL2 | chr20 | 42341699 | - | 0.30341876 | 0.69658124 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >7246_7246_1_ASRGL1-MYBL2_ASRGL1_chr11_62123847_ENST00000301776_MYBL2_chr20_42341699_ENST00000217026_length(amino acids)=160AA_BP=1 MKGQLSARIETWAVWTSSASHPLFHDKPSKFNGICYTLDCGHCSCRQVFSIHDCVELGIVFQGDDSSLYGIHGAPALPEDAVAHGGGSDH -------------------------------------------------------------- >7246_7246_2_ASRGL1-MYBL2_ASRGL1_chr11_62123847_ENST00000301776_MYBL2_chr20_42341699_ENST00000396863_length(amino acids)=138AA_BP=0 MTLRFTDPLCPHNPCKHENGLVTPSTPQDKMRVRDVWLGFRRPRSCRAFSCMKSWSLVPPQATVFQALDIGAGVVKWLRGFWATAAFSGL -------------------------------------------------------------- >7246_7246_3_ASRGL1-MYBL2_ASRGL1_chr11_62123847_ENST00000415229_MYBL2_chr20_42341699_ENST00000217026_length(amino acids)=151AA_BP= MRAERFRAGVGERRYRAAAGLARPSLRSRRPRPAVPWGLPRTLYPRGFLGLALDDAFAFLLPRIRRHESHRSGPRRRSRSHLQGSEGASA -------------------------------------------------------------- >7246_7246_4_ASRGL1-MYBL2_ASRGL1_chr11_62123847_ENST00000415229_MYBL2_chr20_42341699_ENST00000396863_length(amino acids)=151AA_BP= MRAERFRAGVGERRYRAAAGLARPSLRSRRPRPAVPWGLPRTLYPRGFLGLALDDAFAFLLPRIRRHESHRSGPRRRSRSHLQGSEGASA -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:62123847/chr20:42341699) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
ASRGL1 | MYBL2 |
FUNCTION: Has both L-asparaginase and beta-aspartyl peptidase activity. May be involved in the production of L-aspartate, which can act as an excitatory neurotransmitter in some brain regions. Is highly active with L-Asp beta-methyl ester. Besides, has catalytic activity toward beta-aspartyl dipeptides and their methyl esters, including beta-L-Asp-L-Phe, beta-L-Asp-L-Phe methyl ester (aspartame), beta-L-Asp-L-Ala, beta-L-Asp-L-Leu and beta-L-Asp-L-Lys. Does not have aspartylglucosaminidase activity and is inactive toward GlcNAc-L-Asn. Likewise, has no activity toward glutamine. {ECO:0000269|PubMed:19839645, ECO:0000269|PubMed:27106100}. | FUNCTION: Transcription factor involved in the regulation of cell survival, proliferation, and differentiation. Transactivates the expression of the CLU gene. {ECO:0000269|PubMed:10770937}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | MYBL2 | chr11:62123847 | chr20:42341699 | ENST00000217026 | 0 | 14 | 106_129 | 0 | 701.0 | DNA binding | H-T-H motif | |
Tgene | MYBL2 | chr11:62123847 | chr20:42341699 | ENST00000217026 | 0 | 14 | 157_180 | 0 | 701.0 | DNA binding | H-T-H motif | |
Tgene | MYBL2 | chr11:62123847 | chr20:42341699 | ENST00000217026 | 0 | 14 | 54_77 | 0 | 701.0 | DNA binding | H-T-H motif | |
Tgene | MYBL2 | chr11:62123847 | chr20:42341699 | ENST00000217026 | 0 | 14 | 134_184 | 0 | 701.0 | Domain | HTH myb-type 3 | |
Tgene | MYBL2 | chr11:62123847 | chr20:42341699 | ENST00000217026 | 0 | 14 | 26_77 | 0 | 701.0 | Domain | HTH myb-type 1 | |
Tgene | MYBL2 | chr11:62123847 | chr20:42341699 | ENST00000217026 | 0 | 14 | 78_133 | 0 | 701.0 | Domain | HTH myb-type 2 | |
Tgene | MYBL2 | chr11:62123847 | chr20:42341699 | ENST00000217026 | 0 | 14 | 411_417 | 0 | 701.0 | Motif | Nuclear localization signal | |
Tgene | MYBL2 | chr11:62123847 | chr20:42341699 | ENST00000217026 | 0 | 14 | 564_584 | 0 | 701.0 | Motif | Note=Bipartite nuclear localization signal |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ASRGL1 | chr11:62123847 | chr20:42341699 | ENST00000301776 | - | 1 | 7 | 196_199 | 0 | 309.0 | Region | Note=Substrate binding |
Hgene | ASRGL1 | chr11:62123847 | chr20:42341699 | ENST00000301776 | - | 1 | 7 | 219_222 | 0 | 309.0 | Region | Note=Substrate binding |
Hgene | ASRGL1 | chr11:62123847 | chr20:42341699 | ENST00000415229 | - | 1 | 7 | 196_199 | 0 | 309.0 | Region | Note=Substrate binding |
Hgene | ASRGL1 | chr11:62123847 | chr20:42341699 | ENST00000415229 | - | 1 | 7 | 219_222 | 0 | 309.0 | Region | Note=Substrate binding |
Top |
Fusion Protein Structures |
![]() * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
PDB file >>>149_ASRGL1_62123847_MYBL2_42341699_ranked_0.pdb | ASRGL1 | 62123847 | 62123847 | ENST00000217026 | MYBL2 | chr20 | 42341699 | - | MKGQLSARIETWAVWTSSASHPLFHDKPSKFNGICYTLDCGHCSCRQVFSIHDCVELGIVFQGDDSSLYGIHGAPALPEDAVAHGGGSDH | 160 |
Top |
pLDDT score distribution |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
ASRGL1_pLDDT.png![]() |
MYBL2_pLDDT.png![]() |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
![]() |
Top |
Ramachandran Plot of Fusion Protein Structure |
![]() |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
ASRGL1 | |
MYBL2 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ASRGL1-MYBL2 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ASRGL1-MYBL2 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |